首页 | 官方网站   微博 | 高级检索  
     

制约中药企业做大做强关键要素研究
引用本文:朱文涛,王煊,刘小亚,乔延江. 制约中药企业做大做强关键要素研究[J]. 世界科学技术-中医药现代化, 2014, 16(6): 1235-1239
作者姓名:朱文涛  王煊  刘小亚  乔延江
作者单位:北京中医药大学管理学院 北京 100029;北京中医药大学中药药物经济学评价研究院 北京 100029;北京中医药大学基础医学院 北京 100029;北京康派特医药经济技术研究中心 北京 100061;北京中医药大学中药学院 北京 1000102
摘    要:通过文献研究及调查研究发现,中药企业发展过程中存在着中药材质量难保证、中药材资源难持续、同质化现象严重、中药产品临床定位不清,适应证不明确、产品缺乏有利的循证医学及药物经济学数据支持、缺乏系统的安全性评价研究等制约因素。为促进中药企业健康发展,提出应保证中药材质量及资源可持续发展;系统地开展循证药物经济学研究,明确临床定位;系统地开展安全性评价,完善说明书;完善以临床有效性为导向的质量标准。

关 键 词:中药企业 健康发展 制约因素 建议
收稿时间:2013-09-14
修稿时间:2013-09-23

Study on Restrictive Critical Factors and Research of Traditional Chinese Medicine Enterprises Become Bigger and Stronger
Zhu Wentao,Wang Xuan,Liu Xiaoya and Qiao Yanjiang. Study on Restrictive Critical Factors and Research of Traditional Chinese Medicine Enterprises Become Bigger and Stronger[J]. World Science and Technology—Modernization of Traditional Chinese Medicine and Materia Medica, 2014, 16(6): 1235-1239
Authors:Zhu Wentao  Wang Xuan  Liu Xiaoya  Qiao Yanjiang
Affiliation:General Department of Business Administration, Beijing University of Chinese Medicine, Beijing 100029, China; Institute of Pharmaceutical Economics Evaluation, Beijing University of Chinese Medicine, Beijing 100029, China;School of Preclinical Medicine, Beijing University of Chinese Medicine, Beijing 100029, China;Beijing Compete Research Center for Pharmaceutical Economics and Technology, Beijing 100061, China;School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China
Abstract:The literature study and survey revealed existed problems and factors such as the difficulties to maintain quality of traditional Chinese medicine (TCM), sustainable development, homogenization and indeterminacy of clinical orientation diagnosis, lack of favorable evidence-based medicine and pharmacoeconomics data to support, lack of evidence of safety evaluation, which restrict the development of TCM enterprises. Based on problems and factors mentioned above, recommendations were made on the healthy development of TCM enterprises, which include guarantee of the quality of TCM herbs and the sustainable development of its resource; conduct systematic evidence-based pharmacoeconomic research, identify the clinical orientation; carry out safety assessment systematically, improve the specification; improve clinical effectiveness-oriented quality standards.
Keywords:Traditional Chinese medicine industry   healthy development   restrictive critical factor   suggestion
点击此处可从《世界科学技术-中医药现代化》浏览原始摘要信息
点击此处可从《世界科学技术-中医药现代化》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号